Status:
UNKNOWN
Diagnostic Classifier for Cutaneous T-cell Lymphomas
Lead Sponsor:
Medical University of Vienna
Conditions:
CTCL/ Mycosis Fungoides
Eligibility:
All Genders
18-100 years
Brief Summary
Primary cutaneous T-cell lymphomas (CTCL) are a form of skin cancer that is derived from immune cells. The most common form of CTCL is mycosis fungoides (MF). While initially confined to the skin, MF ...
Eligibility Criteria
Inclusion
- Clinical and/or histopathological diagnosis of MF, eczema or psoriasis
- Healthy control subjects without personal history of MF, eczema or psoriasis
Exclusion
- Ongoing skin-targeted treatment (Wash out times: 2 weeks for topical, and 4 weeks for systemic treatments)
- Ongoing other treatment that might, in the opinion of the investigator, influence proteomic features of the samples to be acquired
Key Trial Info
Start Date :
February 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04491825
Start Date
February 22 2021
End Date
June 30 2024
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090